With today’s insane cost of living, if there’s a cheaper option to something you best believe I’m picking it. I am all about home brand cheese and ibuprofen sans shiny box. Pharmaceutical company Acrux (ASX: ACR) gets it, having lodged an application with the US Food and Drug Administration (FDA) for review of their generic
Read More
Aptar Pharma has deemed now the perfect time to exercise their option to purchase an inventive piece of Pharmaxis’ (ASX: PXS) technology. In August, 2021 Aptar signed an exclusive option agreement to Pharmaxis’ “Orbital” technology, handing over USD $250,000. Now, a little under a year later, Aptar is deploying USD $2.5 million to exercise the
Read More
Four months since appointing receivers to untangle the mess of a business created by Buddy Technologies (ASX: BUD), receivers have found one asset of value to sell off but that won’t come even remotely close to paying off debts owed by the tech company which has been suspended by the ASX since April 2022 following
Read More
Medical equipment manufacturing company Allegra Orthopaedics (ASX: AMT) reveals further evidence of safety of its bone regeneration device after completing a large animal study. The animal study was undertaken at SAHMRI-PIRL (South Australian Health and Medical Research Institute – Preclinical, Imaging and Research Laboratories) under good laboratory practice (GLP) conditions. The research has now progressed
Read More
I recently bought a gorgeous coat from an American website. This thing has travelled the world, having been made in Italy before making its way to some warehouse in the States and finally, to protect me from the Melbourne cold. When you think about it, the air miles on this thing are insane. Aside from
Read More
Although there is a global shortage in their products, semiconductor tech company Revasum (ASX: RVS) continues to be plagued by cash flow problems despite delivering a 60% increase in revenue with their struggles being attributed to supply chain problems. The Company revealed a revenue uptick from USD $7.4 million for the half year ended 30
Read More